Table 2.
Thiol plasma concentrations, FRAP antioxidant capacity, protein carbonyl plasma levels, TBARS plasma levels and ROS production in whole blood of patients with CP and controls mean (range)
| Measure for oxidative stress | CP patients | Controls |
| Cys1 (μmol/L) | 225 (124-314)a | 249 (212-328) |
| Hcys2 (μmol/L) | 13.6 (5.0-38.2) | 12.7 (0.2-27.8) |
| CGS3 (μmol/L) | 34.8 (23.5-124)a | 39.3 (25.2-56.7) |
| GSH4 (μmol/L) | 7.5 (2.4-18.5)a | 8.9 (3.5-16.1) |
| FRAP5 (mmol Fe2+/L) | 0.75 (0.31-1.73)a | 0.99 (0.69-1.57) |
| Carbonyls (nmol/mg protein) | 0.32 (0.02-1.47)a | 0.04 (0.01-0.07) |
| TBARS6 (μmol/L) | 4.98 (0.23-27.79)a | 0.35 (0.04-0.68) |
| ROS7 production (RLU/104 cells) | ||
| PMA8-stimulated | 40 (1-83) | 33 (1-87) |
| STZ9-stimulated | 124 (11-266) | 111 (9-2130) |
1
Cysteine;
2
Homocysteine;
3
Cysteinylglycine;
4
Glutathione;
5
Ferric reducing ability of plasma;
6
Thiobarbituric acid-reactive substances; 7Reactive oxygen species;
8
Phorbol 12-myritate 13-acetate;
9
Serum treated zymosan.
a
P < 0.05 vs control.